|
|
||||||||
The Journal of Immunology, Vol 159, Issue 2 614-622, Copyright © 1997 by American Association of Immunologists
ARTICLES |
JP Aubry, N Dugas, S Lecoanet-Henchoz, F Ouaaz, H Zhao, JF Delfraissy, P Graber, JP Kolb, B Dugas and JY Bonnefoy
Geneva Biomedical Research Institute, Immunology Department, GlaxoWellcome, Switzerland.
CD23, a low-affinity receptor for IgE, was recently shown to bind to CD11b and CD11c molecules on human monocytes. The 25-kDa soluble fragment of CD23 (sCD23), was tested for its capacity to elicit various signaling pathways in human monocytes. sCD23 was found to trigger an early increase in cGMP accumulation, through the generation of nitric oxide. This was a result of activating the L-arginine pathway, since the sCD23-mediated effect was inhibited in the presence of substituted nonmetabolizable L-arginine analogues. In addition, the increase in cGMP was suppressed by calcium chelators and inhibitors of the calcium/calmodulin complex, suggesting the involvement of a constitutive, calcium-dependent nitric oxide synthase (NOS). Indeed, the presence of an endothelial constitutive type III NOS mRNA was detected in nonactivated human monocytes, and the corresponding protein has been detected by flow cytometry. Moreover, sCD23 was shown to induce a calcium influx in monocytes, in accordance with an activation of a constitutive NOS through a transient increase in [Ca2+]i. As expected, these events were mimicked by mAbs against CD11b and CD11c, the macrophage receptors for CD23. In addition to these early events, sCD23 and the agonistic anti-CD11b and CD11c mAbs, which all trigger the release of proinflammatory mediators such as TNF-alpha, were shown to act through an NO-dependent process.
This article has been cited by other articles:
![]() |
G. A. Lemieux, F. Blumenkron, N. Yeung, P. Zhou, J. Williams, A. C. Grammer, R. Petrovich, P. E. Lipsky, M. L. Moss, and Z. Werb The Low Affinity IgE Receptor (CD23) Is Cleaved by the Metalloproteinase ADAM10 J. Biol. Chem., May 18, 2007; 282(20): 14836 - 14844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vega, P. Chacon, J. Monteseirin, R. El Bekay, M. Alvarez, G. Alba, J. Conde, J. Martin-Nieto, F. J. Bedoya, E. Pintado, et al. A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression J. Leukoc. Biol., June 1, 2004; 75(6): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Teige, A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas IFN-{beta} Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis J. Immunol., May 1, 2003; 170(9): 4776 - 4784. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Gantt, T. L. Goldman, M. L. McCormick, M. A. Miller, S. M. B. Jeronimo, E. T. Nascimento, B. E. Britigan, and M. E. Wilson Oxidative Responses of Human and Murine Macrophages During Phagocytosis of Leishmania chagasi J. Immunol., July 15, 2001; 167(2): 893 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rezzonico, V. Imbert, R. Chicheportiche, and J.-M. Dayer Ligation of CD11b and CD11c {beta}2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} production in primary human monocytes through a pathway dependent on nuclear factor-{kappa}B Blood, May 15, 2001; 97(10): 2932 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rezzonico, R. Chicheportiche, V. Imbert, and J.-M. Dayer Engagement of CD11b and CD11c beta 2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways Blood, June 15, 2000; 95(12): 3868 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adachi, A. L. Kindzelskii, N. Ohno, T. Yadomae, and H. R. Petty Amplitude and Frequency Modulation of Metabolic Signals in Leukocytes: Synergistic Role of IFN-{gamma} in IL-6- and IL-2-Mediated Cell Activation J. Immunol., October 15, 1999; 163(8): 4367 - 4374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Poudrier, P. Graber, S. Herren, D. Gretener, G. Elson, C. Berney, J.-F. Gauchat, and M. H. Kosco-Vilbois A Soluble Form of IL-13 Receptor {alpha}1 Promotes IgG2a and IgG2b Production by Murine Germinal Center B Cells J. Immunol., August 1, 1999; 163(3): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Srivastava and H. I. Magazine Thrombin Receptor Activation Inhibits Monocyte Spreading by Induction of ETB Receptor-Coupled Nitric Oxide Release J. Immunol., November 1, 1998; 161(9): 5039 - 5044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zaffran, L. Zhang, and J. J. Ellner Role of CR4 in Mycobacterium tuberculosis-Human Macrophages Binding and Signal Transduction in the Absence of Serum Infect. Immun., September 1, 1998; 66(9): 4541 - 4544. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, N. Dugas, C. Mathiot, A. Delmer, B. Dugas, F. Sigaux, and J.-P. Kolb B-Cell Chronic Lymphocytic Leukemia Cells Express a Functional Inducible Nitric Oxide Synthase Displaying Anti-Apoptotic Activity Blood, August 1, 1998; 92(3): 1031 - 1043. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |